Kathleen A. Rickard - Feb 1, 2022 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Chief Medical Officer
Signature
/s/ Claire Poll, Attorney-in-fact for Kathleen Rickard
Stock symbol
VRNA
Transactions as of
Feb 1, 2022
Transactions value $
-$49,335
Form type
4
Date filed
2/3/2022, 04:57 PM
Previous filing
Nov 3, 2021
Next filing
Apr 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Tax liability -$49.3K -63.6K -2.28% $0.78* 2.72M Feb 1, 2022 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Represents the number of Ordinary Shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported Restricted Share Units.
F3 The price reported represents the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on January 31, 2022 divided by eight (8).
F4 Consists of (i) 1,916,968 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 239,621 ADSs); and (ii) 801,960 Ordinary Shares underlying 100,245 ADSs.